ExoAtlet is a pioneering healthtech company at the forefront of wearable medical robotics, specializing in exoskeletons designed to restore mobility and support rehabilitation for individuals with lower-limb impairments. Founded in 2014 and headquartered in Luxembourg, ExoAtlet has established a global presence across Europe and Asia, providing innovative solutions that enhance the quality of life for patients with spinal cord injuries, strokes, cerebral palsy, multiple sclerosis, and other neurological or traumatic conditions.

The company’s exoskeleton lineup includes the ExoAtlet I and II, the ExoAtlant Torso, and the ExoAtlet Bambini, the first pediatric exoskeleton for children with neurological disorders. These devices are engineered to deliver safe, effective gait rehabilitation, combining advanced robotics, real-time monitoring, and adaptive support to optimize therapy outcomes. ExoAtlet integrates cutting-edge technologies such as smart crutches, virtual reality interfaces, and neural control systems to provide personalized rehabilitation experiences.

ExoAtlet collaborates closely with research institutions and medical centers to continually innovate and expand the applications of wearable robotics in healthcare. With over 70 clinics equipped and more than 6,000 patients assisted, ExoAtlet demonstrates its commitment to accessibility, precision, and patient-centered care. By bridging robotics and rehabilitation, ExoAtlet empowers patients to regain independence, mobility, and confidence, solidifying its reputation as a global leader in exorehabilitation technology.